Final Results of First European Phase Ii Trial of Intravenous Cetuximab (Cet) and Hepatic Artery Infusion of Irinotecan, 5-Fluorouracil, and Oxaliplatin in Patients (Pts) with Unresectable Liver Metastases from Wt Kras Colorectal Cancer (Lm-Crc) After Systemic Treatment Failure (Optiliv, Nct00852228).

AuthID
P-00P-8P8
20
Author(s)
Smith, D
·
Lepere, C
·
Focan, CNJ
·
Guimbaud, R
·
Carvalho, C
·
Tumolo, S
·
Innominato, PF
·
Ajavon, Y
·
Truant, S
·
Castaing, D
·
De Baere, T
·
Kunstlinger, F
·
Karaboue, A
·
Bouchahda, M
·
Rougier, PR
·
Adam, R
·
Ducreux, M
1
Group Author(s)
ARTBC Int
Document Type
Abstract
Year published
2013
Published
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 31, Issue: 4
Conference
Gastrointestinal Cancers Symposium of the American-Society-Of-Clinical-Oncology (Asco), Date: JAN 24-26, 2013, Location: San Francisco, CA, Sponsors: Amer Soc Clin Oncol
Indexing
Publication Identifiers
Wos: WOS:000333679000457
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.